secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0000950170-25-056736
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises $2.0M in registered direct offering at $0.862/share
-----------------------------------------------------------------

- Sold 2,324,000 shares at $0.862 each, gross proceeds ~$2.0M; net ~$1.8M after fees.
- Roth Capital Partners acted as exclusive placement agent, receiving 7.0% cash fee.
- Proceeds to fund clinical programs, working capital, and general corporate purposes.
- Offering closed April 22, 2025; 5-day lockup on further equity issuance following close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025056736/0000950170-25-056736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025056736/apvo-20250421.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-056736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer